RKWD

ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|

Rockwood Research

MDLN

Medline Inc.

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 2046386Held by 11 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

i

12 of 12 reported changes in each tracked manager’s latest 13F vs its prior quarter (2 reporting periods). Every change is listed — no cap.

ManagerActionShare change% chgEnding % of 13F bookPosition size

Bridgewater Associates

Q2 2026Position history →

New+19,847—<0.01%$<0.01B

Capital Research Global Investors

Q2 2026Position history →

Add+16,802,120+72.5%0.22%$1.58B

Lone Pine Capital

Q2 2026Position history →

Add+9,179,211+77.9%5.1%$0.83B

Egerton Capital

Q2 2026Position history →

Add+12,105,082+277.3%6.3%$0.65B

WCM Investment Management

Q2 2026Position history →

Add+178,919+2.5%0.53%$0.29B

Eminence Capital

Q1 2026Position history →

Add+774,190+51.4%2.3%$0.10B

Soros Fund Management

Q2 2026Position history →

Add+351,810+27.3%0.85%$0.06B

Viking Global Investors

Q2 2026Position history →

Trim(6,592,912)(57.7%)0.54%$0.19B

Durable Capital Partners

Q2 2026Position history →

Trim(4,638,532)(63.8%)1.0%$0.10B

Capital World Investors

Q2 2026Position history →

Trim(3,775,201)(87.6%)<0.01%$0.02B

Holocene Advisors

Q2 2026Position history →

Exit(832,316)(100.0%)exited$0.04B

Maverick Capital

Q2 2026Position history →

Exit(796,077)(100.0%)exited$0.04B

Changes compare each manager’s latest 13F with its prior quarter for the same CUSIP. “First observation” rows have no earlier stored filing to compare and are never counted as buys; “Split?” rows moved by a near-whole factor at an unchanged value and are treated as stock splits, not trades. Ending weight is the position after the change, not the size of the change.